Insider · CIK 0001664506

Jones William Benton

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001664506

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-04	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+400K sh	—	—	400,000
2025-06-04	CRVSCorvus Pharmaceuticals, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+19.4K sh	$3.50	+$67.7K	173,130
2025-06-04	CRVSCorvus Pharmaceuticals, Inc. · Warrant (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−19.4K sh	—	—	0
2024-12-20	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+300K sh	—	—	300,000
2024-05-06	CRVSCorvus Pharmaceuticals, Inc.P Purchase	See Remarks	PPurchase	+20K sh	$1.73	+$34.6K	153,773
2024-05-06	CRVSCorvus Pharmaceuticals, Inc. · Warrant (Right to Buy)P Purchase	See Remarks	PPurchase	+19.4K sh	—	—	19,357
2023-12-06	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000
2022-12-20	CRVSCorvus Pharmaceuticals, Inc.P Purchase	See Remarks	PPurchase	+20K sh	$0.79	+$15.8K	133,773
2022-08-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+160K sh	—	—	160,000
2021-09-09	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+160K sh	—	—	160,000
2020-12-16	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+160K sh	—	—	160,000
2019-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+160K sh	—	—	160,000
2018-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2017-12-13	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000
2016-12-07	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+25K sh	—	—	25,000
2016-03-22	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Dec 84
Jones William Benton0001610717-25-000412
SEC(opens sec.gov)
Jun 64
Jones William Benton0001610717-25-000174
SEC(opens sec.gov)
Dec 234
Jones William Benton0001610717-24-000552
SEC(opens sec.gov)
May 74
Jones William Benton0001610717-24-000232
SEC(opens sec.gov)
Dec 84
Jones William Benton0001610717-23-000392
SEC(opens sec.gov)
Dec 204
Jones William Benton0001567619-22-021876
SEC(opens sec.gov)
Aug 154
Jones William Benton0001567619-22-016300
SEC(opens sec.gov)
Sep 134
Jones William Benton0001567619-21-017013
SEC(opens sec.gov)
Dec 174
Jones William Benton0001567619-20-021269
SEC(opens sec.gov)
Dec 164
Jones William Benton0001567619-19-023140
SEC(opens sec.gov)
Dec 144
Jones William Benton0000899243-18-031061
SEC(opens sec.gov)
Dec 154
Jones William Benton0000899243-17-028856
SEC(opens sec.gov)
Dec 84
Corvus Pharmaceuticals, Inc.0001140361-16-089147
SEC(opens sec.gov)
Mar 244
Corvus Pharmaceuticals, Inc.0001104659-16-107420
SEC(opens sec.gov)

Companies

Corvus Pharmaceuticals, Inc.See RemarksCRVS

Address

C/O CORVUS PHARMACEUTICALS, INC. 901 GATEWAY BOULEVARD, THIRD FLOOR

SOUTH SAN FRANCISCO, CA, 94080